Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Lorcaserin: balancing efficacy with potential risks

Obesity remains among the most difficult diseases to treat, with lifestyle changes not always leading to sufficient weight loss or sustained long-term results.1 The history of weight-loss medications has been challenging because of adverse effects restricting their application.2 Given the worldwide obesity and diabetes twin epidemics,3 demands for effective treatments both from patients and physicians are high.